Intensive care management of patients following haematopoietic stem cell transplantation

Current Anaesthesia and Critical Care

Volumn 19, Issue 2, 2008, Pages 80-90

  Pawson, Helen ^a   Jayaweera, Asantha ^a   Wigmore, Tim ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Bone marrow transplant; Complications; Haemotopoietic stem cell transplant; Intensive care unit

Indexed keywords

ALTEPLASE; ANALGESIC AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; BUSULFAN; CEPHALOSPORIN DERIVATIVE; CISPLATIN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DEFIBROTIDE; DIMETHYL SULFOXIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ETOPOSIDE; GANCICLOVIR; GEMTUZUMAB OZOGAMICIN; GRANULOCYTE COLONY STIMULATING FACTOR; HEPARIN; IMMUNOSUPPRESSIVE AGENT; INOTROPIC AGENT; MACROLIDE; MELPHALAN; OKT 3; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SEDATIVE AGENT; UNINDEXED DRUG; URSODEOXYCHOLIC ACID;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE KIDNEY FAILURE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ARTIFICIAL VENTILATION; ASEPTIC MENINGITIS; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BACTERIAL INFECTION; BRAIN DISEASE; BRAIN EDEMA; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CARDIOTOXICITY; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROVASCULAR ACCIDENT; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; CONGESTIVE HEART FAILURE; CONSCIOUSNESS DISORDER; CRYOPRESERVATION; DIAGNOSTIC ERROR; DOSE RESPONSE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ENDOCARDITIS; ENDOTHELIUM INJURY; ENGRAFTMENT SYNDROME; ENTERITIS; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART SURGERY; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMODIALYSIS; HEMORRHAGIC CYSTITIS; HUMAN; ILEUS; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION RISK; INTENSIVE CARE; LEUKEMIA; LIVER BIOPSY; LIVER DYSFUNCTION; LIVER VENOOCCLUSIVE DISEASE; LUNG EDEMA; LUNG HEMORRHAGE; METABOLIC ENCEPHALOPATHY; MYCOSIS; MYOPATHY; NEPHROTOXICITY; PATHOPHYSIOLOGY; PERICARDIAL EFFUSION; PERICARDIOTOMY; PLASMAPHERESIS; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSIS; RISK FACTOR; SEIZURE; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME; TUMOR LYSIS SYNDROME; VIRUS INFECTION; VISUAL DISORDER; WHOLE BODY RADIATION;

EID: 41149164898     PISSN: 09537112     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cacc.2008.01.005     Document Type: Article

References (87)

1. Afessa B., Tefferi A., Hoagland H.C., et al. Outcome of recipients of bone marrow transplants who require intensive-care unit support. Mayo Clin Proc 67 (1992) 117-122
2. Soubani A.O., Kseibi E., Bander J.J., et al. Outcome and prognostic factors of haematopoietic stem cell transplantation recipients admitted to a medical ICU. Chest 126 (2004) 1604-1611
3. Lee C., Gingrich R.D., Hohl R.J., and Ajram K.A. Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation. Bone Marrow Transplant 16 (1995) 175-182
4. Cahill R., Spitzer T.R., and Mazumder A. Marrow engraftment and clinical manifestations of capillary leak syndrome. Bone Marrow Transplant 18 (1996) 177-184
5. Ravoet C., Feremans W., Husson B., et al. Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantation. Bone Marrow Transplant 18 (1996) 943-947
6. Moreb J., Kubilis P.S., Mullins D.L., et al. Increased frequency of autoaggression syndrome associated with autologous stem cell transplantation in breast cancer patients. Bone Marrow Transplant 19 (1997) 101-106
7. Edenfield W., Moores L.K., Goodwin G., and Lee N. An engraftment syndrome in autologous stem cell transplantation related to mononuclear cell dose. Bone Marrow Transplant 25 (2000) 405-409
8. Nurnberger W., Willers R., Burdach S., and Gobel U. Risk factors for capillary leakage syndrome after bone marrow transplantation. Ann Hematol 74 (1997) 221-224
9. Antin J., and Ferrara L. Cytokine dysregulation and acute graftversus-host disease. Blood 80 (1992) 2964-2968
10. Rabinowitz J., Petros W.P., Stuart A.R., and Peters W.P. Characterization of endogenous cytokine concentrations after high-dose chemotherapy with autologous bone marrow support. Blood 81 (1993) 2452-2459
11. Salat C., Holler E., Schleuning M., et al. Levels of the terminal complement complex, C3a-desArg and C1-inhibitor in adult patients with capillary leak syndrome following bone marrow transplantation. Ann Hematol 71 (1995) 271-274
12. Ferrara J., Levy R., and Chao N.J. Pathophysiologic mechanisms of acute graft-vs-host disease. Biol Blood Marrow Transplant 5 (1999) 347-356
13. Takatsuka H., Takemoto Y., Yamada S., et al. Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome. Bone Marrow Transplant 26 (2000) 419-426
14. Rabitsch W., Staudinger T., Brugger S.A., et al. Successful management of adult respiratory distress syndrome (ARDS) after high-dose chemotherapy and peripheral blood progenitor cell rescue by non-invasive ventilatory support. Bone Marrow Transplant 21 (1998) 1067-1069
15. Ohsaka A., Kitagawa S., Sakamoto S., et al. In vivo activation of human neutrophil functions by administration of recombinant human granulocyte colony-stimulating factor in patients with malignant lymphoma. Blood 74 (1989) 2743-2748
16. Ericson S.G., Zhao Y., Gao H., et al. Interleukin-6 production by human neutrophils after Fc-receptor cross-linking or exposure to granulocyte colony-stimulating factor. Blood 91 (1998) 2099-2107
17. Karlin L., Darmon M., Thiery G., et al. Respiratory status deterioration during G-CSF-induced neutrophil recovery. Bone Marrow Transplant 36 (2005) 245-250
18. Crilley P., Topolsky D., Styler M.J., Bernstein E., Resnick K., Mullaney R., et al. Extramedullary toxicity of a conditioning regimen containing busulphan, cyclophosphamide and etoposide in 84 patients undergoing autologous and allogenic bone marrow transplantation. Bone Marrow Transplant 15 (1995) 361-365
19. Ho V.T., Weller E., Lee S.J., Alyea E.P., Antin J.H., and Soiffer R.J. Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 7 (2001) 223-229
20. Lewis I.D., DeFor T., and Weisdorf D.J. Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy. Bone Marrow Transplant 26 (2000) 539-543
21. Metcalf J.P., Rennard S.I., Reed E.C., Haire W.D., Sisson J.H., Walter T., et al. Corticosteroids as adjunctive therapy for diffuse alveolar hemorrhage associated with bone marrow transplantation: University of Nebraska medical center bone marrow transplant group. Am J Med 96 (1994) 327-334
22. Nevo S., Swan V., Enger C., Wojno K.J., Bitton R., Shabooti M., et al. Acute bleeding after bone marrow transplantation (HSCT): incidence and effect on survival: a quantitative analysis in 1,402 patients. Blood 91 (1998) 1469-1477
23. Sisson J.H., Thompson A.B., Anderson J.R., Robbins R.A., Spurzem J.R., Spence P.R., et al. Airway inflammation predicts diffuse alveolar hemorrhage during bone marrow transplantation in patients with Hodgkin disease. Am Rev Respir Dis 146 (1992) 439-443
24. Witte R.J., Gurney J.W., Robbins R.A., Linder J., Rennard S.I., Arneson M., et al. Diffuse pulmonary alveolar hemorrhage after bone marrow transplantation: radiographic findings in 39 patients. Am J Roentgenol 157 (1991) 461-464
25. Meyers J.D., Flournoy N., and Thomas E.D. Non-bacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience. Rev Infect Dis 4 (1982) 1119-1132
26. Wingard J.R., Mellits E.D., Sostrin M.B., et al. Interstitial pneumonitis after allogeneic bone marrow transplantation: nine-year experience at a single institution. Medicine (Baltimore) 67 (1988) 175-186
27. Crawford S.W., Longton G., and Storb R. Acute graft-versus-host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anaemia. Bone Marrow Transplant 12 (1993) 225-231
28. Bearman S.I., Peterson F.B., Schor R.A., et al. Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: risk for cardiac toxicity. Bone Marrow Transplant 4 (1990) 173-177
29. Akahori M., Nakamae H., Hino M., et al. Electrocardiogram is very useful for predicting acute heart failure following myeloablative chemotherapy with haematopietic stem cell transplantation rescue. Bone Marrow Transplant 31 (2003) 585-590
30. Cazin B., Gorin N.C., Laporte J.P., et al. Cardiac complications after bone marrow transplantation: a report on a series of 63 consecutive transplantations. Cancer 57 (1986) 2061-2069
31. Enhausern R., Tobler A., Leoncini L., et al. Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved haematopoietic stem cells in a patient with sever primary cardiac amyloidosis and end-stage renal failure. Ann Hematol 79 (2000) 533-553
32. Ori T., Yanagi N., Maruyama T., et al. Left ventricular systolic dysfunction induced by cyclophospamide in blood stem cell transplantation. Jpn Heart J 43 (2002) 249-261
33. Kuruvilla J., Forrest D.L., Lavoie J.C., et al. Characteristics and outcome of patients developing endocarditis following haematopoietic stem cell transplantation. Bone Marrow Transplant 34 (2004) 969-973
34. Hidalgo J.D., Krone R., Rich M.W., et al. Supraventricular tachyarrhythmias after haematopoietic stem cell transplantation: incidence, risk factors, and outcomes. Bone Marrow Transplant 34 (2004) 615-619
35. Kalayoglu-Besisik S., Yenerel M.N., Caliskan Y., et al. Time-related changes in the incidence, severity, and clinical outcome of hepatic veno-occlusive disease in haematopoietic stem cell transplantaion patients during the past 10 years. Transplant Proc 37 (2005) 2285-2289
36. Bearman S.I., Lee J.L., Baron A.E., et al. Treatment of hepatic venoocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients. Blood 89 (1997) 1501-1506
37. Coplin W.M., Cochran M.S., Levine S.R., et al. Stroke after bone marrow transplantation: frequency, aetiology and outcome. Brain 124 (2001) 1043-1051
38. Graus F., Saiz A., Sierra J., et al. Neurological complications of autologous and allogeneic bone marrow transplantation in patients with leukaemia: a comparative study. Neurology 46 (1996) 1004-1009
39. Hauben M. Cyclosporin Neurotoxicity Pharmacother 16 (1996) 576-583
40. Min D.I., and Monaco A.P. Complications associated with immunosuppressive therapy and their management. Pharmacotherapy 11 5 (1991) 119S-125S
41. Poutsiaka, et al. Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality. Bone Marrow Transplant 40 1 (2007) 63-70
42. Leung A.N., et al. Pulmonary Infections after bone marrow transplantation: clinical and radiographic findings. Radiology 210 (1999) 699-710
43. Dichter J., et al. Approach to the immunocompromised host with pulmonary symptoms. Hematol/Oncol Clin N Am 7 (1993) 887-912
44. W ah T.M., et al. Pulmonary complications following bone marrow transplantation. Br J Radiol 76 (2003) 373-379
45. Haake, et al. Cytomegalovirus pneumonia after bone marrow transplantation. Transplantation 55 6 (1993) 1339-1345
46. Gasparetto E.L., et al. Cytomegalovirus pneumonia after bone marrow transplantation: high resolution CT findings. Br J Radiol 77 (2004) 724-727
47. Nichols W.G., et al. Management of infectious complications in the hematopoietic stem cell transplant recipient. J Intensive Care Med 18 (2003) 295-312
48. Soubani, et al. Pulmonary complications of bone marrow transplantation. Chest 109 (1996) 1066-1077
49. Winston, et al. Prophylaxis and treatment of infection in the bone marrow transplant recipient. Curr Clin Topics Infect Dis 13 (1993) 293-321
50. Sable, et al. Infections in bone marrow transplant recipients. Clin Infect Dis 18 (1994) 273-281
51. Small, et al. Respiratory syncytial virus infection following hematopoietic stem cell transplantation. Bone Marrow Transplant 29 (2002) 321-327
52. Boeckh, et al. Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants. J Infect Dis 184 (2001) 350-354
53. Raman, et al. Fungal infections in bone marrow transplant recipients. Expert Opinion Pharmacother 7 3 (2006) 307-315
54. De La Rosa, et al. Risk factors for the development of invasive fungal infections in allogeneic blood and marrow transplant recipients. Transplant Infect Dis 4 1 (2002) 3-9
55. Blumberg, et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. Clin Infect Dis 33 (2001) 177-186
56. Ascioglu, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34 (2002) 7-14
57. Kanda, et al. Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 RCTs. Cancer 89 (2000) 1611-1625
58. Pagano, et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study. Clin Infect Dis 45 (2007) 1161-1170
59. Logan, et al. Invasive aspergillosis of the airways: radiographic, CT and pathologic findings. Radiology 193 (1994) 383-388
60. Caillot, et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 15 (1997) 139-147
61. Maertens, et al. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 97 (2001) 1604-1610
62. Maertens, et al. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin Infect Dis 39 (2004) 1563-1571
63. Herbrecht, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Eng J Med 347 (2002) 408-415
64. Soubani. Critical care considerations of haemopoietic stem cell transplantation. Crit Care Med 34 (2006) 251-267
65. Ko, et al. Acute pancreatitis in marrow transplant patients: prevalence at autopsy and risk factor analysis. Bone Marrow Transplant 20 (1997) 1081-1086
66. Weisdorf, et al. Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy. Blood 76 (1990) 624
67. Kanfer, et al. Severe rotavirus-associated diarrhoea following bone marrow transplantation: treatment with oral immunoglobulin. Bone Marrow Transplant 14 (1994) 651-652
68. Urbach, et al. Typhlitis. Cancer J Surg 42 (1999) 415-419
69. Kaur, et al. Incidence and outcome of overt gastrointestinal bleeding in patients undergoing bone marrow transplantation. Dig Dis Sci 41 (1996) 598-603
70. Kanamori, et al. Diagnostic value of hemostatic parameters in bone marrow transplantation-associated thrombotic microangiopathy. Bone Marrow Transplant 21 (1998) 705-709
71. Iacopino, et al. Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation. Bone Marrow Transplant 24 (1999) 47-51
72. Allford, et al. Thrombotic thrombocytopenic purpura following stem cell transplantation. Leuk Lymphoma 43 (2002) 1921-1926
73. Lucas L., et al. Post-transplant Epstein-Barr virus induced lymphoproliferative disorders. Leuk Lymphoma 25 (1997) 1-8
74. McGuirk, et al. Use of Rituximab and irradiated donor-derived lymphocytes to control Epstein-Barr virus-associated lymphoproliferation in patients undergoing related haplo-identical stem cell transplantation. Bone Marrow Transplant 24 (1999) 1253-1258
75. Letourneau, et al. Acute renal failure in bone marrow transplant patients admitted to the intensive care unit. Nephron 90 (2002) 408-412
76. Gruss, et al. Acute renal failure in patients following bone marrow transplantation: prevalence, risk factors and outcome. Am J Nephrol 15 (1995) 473-479
77. Pulla, et al. Acute renal failure following bone marrow transplantation. Renal Failure 20 (1998) 421-435
78. Deliliers, et al. Hyperuricemia and bone marrow transplantation. Contrib Nephrol 147 (2005) 105-114
79. Ho, et al. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies. Bone Marrow Transplant (2007) (Nov 12 [Epub ahead of print])
80. Hale, et al. Hemorrhagic cystitis after allogeneic bone marrow transplantation in children: characteristics and outcome. Biol Bone Marrow Transplant 9 (2003) 698-705
81. Hale, et al. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant 23 (1999) 277-282
82. Pahari, et al. BK virus-associated renal problems-clinical implications. Pediatr Nephrol 18 (2003) 743-748
83. Boekh, et al. Emerging viral infections after hematopoietic cell transplantation. Pediatr Transplant 9 (2005) 48-54
84. Russo, et al. Urologic emergencies in the cancer patient. Semin Oncol 3 (2000) 284-298
85. Pene, et al. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. J Clin Oncol 24 (2006) 643-649
86. Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors.
87. Yang, et al. Outcome of hematopoietic stem cell recipients who were mechanically ventilated and admitted to intensive care units. J Formosan Med Assoc 106 (2007) 295-301